“Molecular Characterisation and Therapeutic Implications of FGFR2 Fusions in Tissue and Circulating Tumor DNA from Patients with Intrahepatic Cholangiocarcinoma: A Review”, AGDD, vol. 7, no. 1, pp. 21–26, Aug. 2024, doi: 10.5281/zenodo.22179497.